(Q44641835)

4 December 2017

title

Salvia divinorum use and phenomenology: results from an online survey (English)

1 reference

4 December 2017

1 reference

0 references

H R Sumnall

1

1 reference

4 December 2017

F Measham

series ordinal

2

1 reference

4 December 2017

S D Brandt

series ordinal

3

1 reference

4 December 2017

J C Cole

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

11 October 2010

1 reference

Journal of Psychopharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

25

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

1496-1507

1 reference

Subjective effects of Salvia divinorum: LSD- or marijuana-like?

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Cannabis-induced psychosis-like experiences are associated with high schizotypy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Subjective effects of Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Cannabis use predicts future psychotic symptoms, and vice versa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Pattern of use and subjective effects of Salvia divinorum among recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Hallucinogens on the Internet: a vast new source of underground drug information

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Antidepressant effects of the herb Salvia divinorum: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Internet access to Salvia divinorum: implications for policy, prevention, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Human hallucinogen research: guidelines for safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvia divinorum: effects and use among YouTube users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

College student use of Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Patterns of ketamine use among young injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

LSD produces conditioned place preference in male but not female fawn hooded rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Equasy — An overlooked addiction with implications for the current debate on drug harms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Implications of LSD and experimental mysticism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Psychotomimesis mediated by kappa opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Persistent psychosis associated with salvia divinorum use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Psychometric assessment of the Hallucinogen Rating Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Between prohibitions: patterns and meanings of magic mushroom use in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvia divinorum and salvinorin A: new pharmacologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

[Salvia divinorum--representation of a new drug in the Internet]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Adolescent salvia substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Who is becoming hallucinogen dependent soon after hallucinogen use starts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Non drug use- and drug use-specific spirituality as one-year predictors of drug use among high-risk youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Salvia divinorum: exposures reported to a statewide poison control system over 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385596

21 January 2018

Identifiers

DOI

10.1177/0269881110385596

1 reference

4 December 2017

1 reference